Level 2 · Controlled trialRandomised controlled trial

Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients

Bakalar B, Duska F, Pachl J, Fric M, Otahal M, Pazout J, Andel M

Critical care medicine · 1 February 2006

AUTHORS’ ABSTRACT

The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.

Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.

← All studies